Condition
Endometrial Adenocarcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Endometrial Adenocarcinoma clinical trials that are recruiting, at sites in 8 countries (most in United States (6), Italy (2), Canada (1)). 2 were first registered in the last 30 days. By phase: Phase 2 (3), Phase 3 (1), Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 2New in 30 days
- 8Countries
Newest Endometrial Adenocarcinoma clinical trials
All recruiting trials (10)
-
KRAS Inhibitor ETX-929 in advanced solid tumors
This trial tests ETX-929, alone or with cetuximab, in people whose cancers have KRAS mutations and have progressed after prior therapy.
-
Adjuvant Hypofractionated Radiotherapy for Endometrial Cancer: Safety, Efficacy, and Quality of Life
This study tests whether a shorter course of pelvic radiotherapy is safe and effective for women with non-metastatic endometrial cancer, and how it affects their quality of life.
-
One year vs two years of maintenance immunotherapy for endometrial cancer
This trial tests whether keeping pembrolizumab or dostarlimab for one year works as well as two years for people with advanced, recurrent, or metastatic endometrial cancer who completed initial chemo and anti-PD1 therapy.
-
DBC-664 in adults with solid tumors
A first-in-human study will test DBC-664 to see if it is safe and tolerable in adults with various advanced solid tumors and may hint at anti-tumor activity.
-
Clonal Hematopoiesis Effects with Chemo and Radiation in Solid Cancers
This study tests whether clonal hematopoiesis affects outcomes for adults with solid cancers who are receiving chemotherapy or radiation.
-
Fertility-preserving hysteroscopic treatment outcomes for endometrial cancer and atypical hyperplasia
This project tests whether removing lesions by hysteroscopy combined with hormonal therapy helps women with endometrial cancer or atypical hyperplasia preserve fertility and achieve good pregnancy and cancer-control outcomes.
-
QL1706 therapy for advanced endometrial cancer after PD-1/L1 treatment failure
This study is testing if a new treatment called QL1706, combined with chemotherapy, can help people with advanced endometrial cancer who didn't respond to earlier PD-1/L1 therapy.
-
Personalized treatment options for endometrial cancer
This study is testing different treatment options for women with early-stage endometrial cancer to see which ones work best based on their specific cancer type.
-
Evaluating ACR-368 for treating certain types of cancer
This study is testing a new cancer drug called ACR-368, alone or with a low dose of another medication, to see if it helps people with certain hard-to-treat cancers like ovarian, endometrial, and bladder cancer.
-
Testing nivolumab with or without ipilimumab for recurrent endometrial cancer
This study is testing if adding ipilimumab to nivolumab can help people with recurrent endometrial cancer live longer and feel better compared to just using nivolumab alone.
Related topics
Quick answers
How many Endometrial Adenocarcinoma clinical trials are recruiting right now?
10, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (6 trials), Italy (2 trials), Canada (1 trial), Finland (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.